Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$23.82
HK$37.15B
-23.22
81.83%
0 Buy
1 Hold
1 Sell
Moderate Sell
Alphamab Oncology
HK$10.72
HK$10.44B
40.11
185.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
RemeGen Co. Ltd. Class H
HK$79.00
HK$50.06B
-39.71
362.08%
4 Buy
3 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$64.80
HK$35.22B
37.31
174.61%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$59.25
HK$21.94B
-14.53
47.16%
0 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
23.82
11.14
87.85%
HK:9688
Zai Lab Ltd
13.78
-6.82
-33.11%
HK:9966
Alphamab Oncology
10.52
7.11
208.50%
HK:9995
RemeGen Co. Ltd. Class H
74.95
58.73
362.08%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
61.10
38.85
174.61%
HK:6855
Ascentage Pharma Group International
56.95
17.80
45.47%